Mustang Bio Statistics

Total Valuation

Mustang Bio has a market cap or net worth of $5.33 million. The enterprise value is -$10.93 million.

Market Cap	5.33M
Enterprise Value	-10.93M

Important Dates

The next estimated earnings date is Friday, August 7, 2026, after market close.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Mustang Bio has 7.58 million shares outstanding. The number of shares has increased by 361.67% in one year.

Current Share Class	6.73M
Shares Outstanding	7.58M
Shares Change (YoY)	+361.67%
Shares Change (QoQ)	+3.99%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	19.58%
Float	5.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.62
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.12

Current Ratio	2.12
Quick Ratio	2.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.62% and return on invested capital (ROIC) is -33.15%.

Return on Equity (ROE)	-44.62%
Return on Assets (ROA)	-12.85%
Return on Invested Capital (ROIC)	-33.15%
Return on Capital Employed (ROCE)	-37.01%
Weighted Average Cost of Capital (WACC)	15.68%
Revenue Per Employee	n/a
Profits Per Employee	-$680,750
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.72% in the last 52 weeks. The beta is 2.08, so Mustang Bio's price volatility has been higher than the market average.

Beta (5Y)	2.08
52-Week Price Change	-31.72%
50-Day Moving Average	0.70
200-Day Moving Average	1.04
Relative Strength Index (RSI)	50.28
Average Volume (20 Days)	330,568

Short Selling Information

The latest short interest is 54,570, so 0.72% of the outstanding shares have been sold short.

Short Interest	54,570
Short Previous Month	53,594
Short % of Shares Out	0.72%
Short % of Float	1.02%
Short Ratio (days to cover)	1.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.24M
Pretax Income	-2.72M
Net Income	-2.72M
EBITDA	-3.23M
EBIT	-3.24M
Earnings Per Share (EPS)	-$0.46

Full Income Statement

Balance Sheet

The company has $16.26 million in cash and n/a in debt, giving a net cash position of $16.26 million or $2.15 per share.

Cash & Cash Equivalents	16.26M
Total Debt	n/a
Net Cash	16.26M
Net Cash Per Share	$2.15
Equity (Book Value)	8.60M
Book Value Per Share	1.13
Working Capital	8.75M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.88M
Capital Expenditures	n/a
Depreciation & Amortization	8,500
Net Borrowing	n/a
Free Cash Flow	-4.88M
FCF Per Share	-$0.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mustang Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-361.67%
Shareholder Yield	-361.67%
Earnings Yield	-51.10%
FCF Yield	-91.63%

Analyst Forecast

The average price target for Mustang Bio is $100.00, which is 14,118.68% higher than the current price. The consensus rating is "Buy".

Price Target	$100.00
Price Target Difference	14,118.68%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on January 16, 2025. It was a reverse split with a ratio of 1:50.

Last Split Date	Jan 16, 2025
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	1